Alexander Kaizer
Concepts (454)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 10 | 2024 | 1127 | 1.920 |
Why?
| | Bayes Theorem | 12 | 2025 | 404 | 1.860 |
Why?
| | Medical Futility | 2 | 2024 | 23 | 1.660 |
Why?
| | Models, Statistical | 5 | 2024 | 668 | 1.210 |
Why?
| | Atrioventricular Block | 4 | 2022 | 37 | 1.200 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 234 | 1.130 |
Why?
| | Heart Rate, Fetal | 2 | 2023 | 21 | 1.000 |
Why?
| | Long QT Syndrome | 2 | 2023 | 70 | 0.930 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 363 | 0.880 |
Why?
| | Computer Simulation | 4 | 2024 | 973 | 0.810 |
Why?
| | Laryngopharyngeal Reflux | 4 | 2024 | 15 | 0.800 |
Why?
| | Ritonavir | 1 | 2022 | 74 | 0.770 |
Why?
| | Neoplasms | 5 | 2024 | 2643 | 0.750 |
Why?
| | Bariatric Surgery | 6 | 2020 | 215 | 0.750 |
Why?
| | Weight Loss | 8 | 2023 | 776 | 0.730 |
Why?
| | Obesity, Morbid | 6 | 2020 | 259 | 0.730 |
Why?
| | Tobacco Products | 2 | 2020 | 136 | 0.720 |
Why?
| | Humans | 111 | 2025 | 136750 | 0.700 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 242 | 0.670 |
Why?
| | Neostigmine | 1 | 2020 | 7 | 0.670 |
Why?
| | Pediatric Obesity | 8 | 2020 | 590 | 0.620 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1044 | 0.620 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 30 | 0.600 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.600 |
Why?
| | Data Collection | 1 | 2021 | 667 | 0.590 |
Why?
| | Anaphylaxis | 1 | 2020 | 105 | 0.590 |
Why?
| | Biostatistics | 1 | 2018 | 18 | 0.580 |
Why?
| | Therapeutics | 1 | 2018 | 14 | 0.570 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 27 | 0.540 |
Why?
| | Retrospective Studies | 33 | 2025 | 15499 | 0.520 |
Why?
| | Clinical Protocols | 1 | 2018 | 267 | 0.510 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 71 | 0.500 |
Why?
| | Fetal Diseases | 4 | 2023 | 173 | 0.500 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 991 | 0.490 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 251 | 0.480 |
Why?
| | Ixodidae | 1 | 2015 | 5 | 0.480 |
Why?
| | Prospective Studies | 22 | 2025 | 7572 | 0.480 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 9 | 0.460 |
Why?
| | Treatment Outcome | 18 | 2025 | 10747 | 0.450 |
Why?
| | Manometry | 7 | 2023 | 95 | 0.450 |
Why?
| | Larva | 1 | 2015 | 224 | 0.440 |
Why?
| | Pepsin A | 3 | 2023 | 19 | 0.430 |
Why?
| | Sample Size | 3 | 2024 | 125 | 0.420 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 57 | 0.400 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 15 | 0.400 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.390 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 23 | 0.390 |
Why?
| | Female | 52 | 2025 | 72785 | 0.380 |
Why?
| | Injections, Spinal | 3 | 2025 | 105 | 0.370 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 109 | 0.370 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 249 | 0.360 |
Why?
| | Information Dissemination | 2 | 2024 | 215 | 0.350 |
Why?
| | Enteral Nutrition | 2 | 2025 | 201 | 0.350 |
Why?
| | Obesity | 5 | 2023 | 2982 | 0.350 |
Why?
| | Nerve Block | 3 | 2021 | 73 | 0.340 |
Why?
| | Anesthetics | 2 | 2022 | 81 | 0.340 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2022 | 1462 | 0.330 |
Why?
| | Body Contouring | 2 | 2020 | 9 | 0.330 |
Why?
| | Pain Management | 2 | 2025 | 348 | 0.330 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 15 | 0.320 |
Why?
| | Probability | 4 | 2023 | 304 | 0.320 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 33 | 0.320 |
Why?
| | Adult | 30 | 2025 | 37626 | 0.310 |
Why?
| | Male | 43 | 2025 | 67305 | 0.290 |
Why?
| | Esophagus | 2 | 2020 | 255 | 0.280 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 21 | 0.270 |
Why?
| | Pregnancy | 8 | 2023 | 6727 | 0.270 |
Why?
| | Surgeons | 2 | 2021 | 296 | 0.270 |
Why?
| | Pain, Postoperative | 5 | 2022 | 265 | 0.270 |
Why?
| | Anesthetics, Local | 3 | 2022 | 80 | 0.260 |
Why?
| | Nicotine | 2 | 2020 | 334 | 0.250 |
Why?
| | Child | 19 | 2025 | 21816 | 0.250 |
Why?
| | After-Hours Care | 1 | 2025 | 15 | 0.240 |
Why?
| | Cough | 2 | 2024 | 121 | 0.240 |
Why?
| | Fractures, Multiple | 1 | 2025 | 6 | 0.240 |
Why?
| | Pierre Robin Syndrome | 1 | 2025 | 9 | 0.240 |
Why?
| | Bupivacaine | 2 | 2022 | 32 | 0.230 |
Why?
| | Airway Management | 1 | 2025 | 52 | 0.230 |
Why?
| | Micrognathism | 1 | 2025 | 18 | 0.230 |
Why?
| | Osteogenesis, Distraction | 1 | 2025 | 18 | 0.230 |
Why?
| | Infant | 9 | 2025 | 9395 | 0.230 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 411 | 0.230 |
Why?
| | Cancer Pain | 1 | 2025 | 29 | 0.230 |
Why?
| | Hearing Aids | 2 | 2023 | 77 | 0.230 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 12 | 0.230 |
Why?
| | Mandible | 1 | 2025 | 78 | 0.230 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 401 | 0.220 |
Why?
| | Incidence | 6 | 2023 | 2797 | 0.220 |
Why?
| | Laparoscopy | 2 | 2020 | 464 | 0.220 |
Why?
| | Biometry | 1 | 2024 | 70 | 0.220 |
Why?
| | Body Weight | 2 | 2019 | 985 | 0.220 |
Why?
| | Blood Transfusion | 2 | 2024 | 324 | 0.220 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.210 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 323 | 0.210 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 6 | 0.210 |
Why?
| | Radiation Dosage | 1 | 2025 | 175 | 0.210 |
Why?
| | Myotomy | 1 | 2023 | 13 | 0.210 |
Why?
| | Aged | 17 | 2025 | 23800 | 0.210 |
Why?
| | Atrial Flutter | 1 | 2023 | 35 | 0.210 |
Why?
| | Postoperative Care | 1 | 2025 | 261 | 0.210 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 43 | 0.200 |
Why?
| | Airway Obstruction | 1 | 2025 | 162 | 0.200 |
Why?
| | Heart Arrest | 2 | 2024 | 338 | 0.200 |
Why?
| | Intestinal Atresia | 1 | 2023 | 14 | 0.200 |
Why?
| | Intubation, Intratracheal | 1 | 2025 | 257 | 0.200 |
Why?
| | Predictive Value of Tests | 3 | 2024 | 2021 | 0.200 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 66 | 0.200 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 186 | 0.200 |
Why?
| | Lopinavir | 1 | 2022 | 30 | 0.200 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 29 | 0.200 |
Why?
| | Lidocaine | 1 | 2023 | 42 | 0.200 |
Why?
| | Middle Aged | 19 | 2025 | 33225 | 0.200 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 163 | 0.200 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.200 |
Why?
| | Infant, Newborn | 6 | 2025 | 6031 | 0.200 |
Why?
| | Neutropenia | 1 | 2023 | 146 | 0.190 |
Why?
| | Fetal Heart | 2 | 2019 | 55 | 0.190 |
Why?
| | Triage | 1 | 2024 | 220 | 0.190 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 18 | 0.190 |
Why?
| | Pulmonary Emphysema | 1 | 2025 | 288 | 0.190 |
Why?
| | Electromyography | 1 | 2024 | 401 | 0.190 |
Why?
| | Tremor | 1 | 2022 | 65 | 0.190 |
Why?
| | Tympanoplasty | 1 | 2022 | 8 | 0.190 |
Why?
| | Adolescent | 18 | 2025 | 21380 | 0.190 |
Why?
| | Diaphragm | 2 | 2022 | 42 | 0.190 |
Why?
| | Deafness | 1 | 2023 | 77 | 0.190 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 17 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 58 | 0.190 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 6 | 0.190 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2021 | 22 | 0.180 |
Why?
| | Lung | 3 | 2024 | 4061 | 0.180 |
Why?
| | Funnel Chest | 1 | 2021 | 27 | 0.180 |
Why?
| | Psychological Trauma | 1 | 2022 | 55 | 0.180 |
Why?
| | Telemedicine | 2 | 2021 | 852 | 0.180 |
Why?
| | Vitamin D | 1 | 2025 | 397 | 0.180 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 71 | 0.180 |
Why?
| | Nose Neoplasms | 1 | 2021 | 25 | 0.180 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.180 |
Why?
| | Postoperative Complications | 4 | 2021 | 2639 | 0.180 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 28 | 0.180 |
Why?
| | Patient Handoff | 1 | 2021 | 32 | 0.180 |
Why?
| | Medicare Part D | 1 | 2021 | 25 | 0.180 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 67 | 0.180 |
Why?
| | Prostate | 1 | 2022 | 175 | 0.180 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 35 | 0.180 |
Why?
| | Congenital Microtia | 1 | 2020 | 4 | 0.180 |
Why?
| | Hepatectomy | 1 | 2023 | 249 | 0.180 |
Why?
| | Tumor Burden | 1 | 2022 | 309 | 0.180 |
Why?
| | Fetus | 2 | 2023 | 806 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 74 | 0.170 |
Why?
| | Cystectomy | 1 | 2021 | 37 | 0.170 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 200 | 0.170 |
Why?
| | Ear | 1 | 2020 | 31 | 0.170 |
Why?
| | Risk Factors | 11 | 2025 | 10330 | 0.170 |
Why?
| | Bias | 1 | 2021 | 218 | 0.170 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 212 | 0.170 |
Why?
| | Shock | 1 | 2021 | 95 | 0.170 |
Why?
| | Ocular Hypertension | 1 | 2021 | 67 | 0.170 |
Why?
| | Electrocardiography | 1 | 2023 | 629 | 0.170 |
Why?
| | Drug Costs | 1 | 2021 | 106 | 0.170 |
Why?
| | Prevalence | 3 | 2023 | 2708 | 0.170 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 88 | 0.170 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.160 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 87 | 0.160 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 107 | 0.160 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2105 | 0.160 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 103 | 0.160 |
Why?
| | Hearing Loss | 1 | 2023 | 220 | 0.160 |
Why?
| | Carcinoma | 1 | 2021 | 238 | 0.160 |
Why?
| | Tomography, X-Ray Computed | 3 | 2025 | 2666 | 0.160 |
Why?
| | Cochlear Implantation | 1 | 2021 | 76 | 0.160 |
Why?
| | Tracheostomy | 1 | 2021 | 132 | 0.160 |
Why?
| | Speech Perception | 1 | 2021 | 82 | 0.160 |
Why?
| | Cochlear Implants | 1 | 2021 | 91 | 0.160 |
Why?
| | Lung Neoplasms | 2 | 2023 | 2489 | 0.160 |
Why?
| | Hyperplasia | 1 | 2020 | 175 | 0.160 |
Why?
| | Exercise | 3 | 2020 | 2044 | 0.160 |
Why?
| | Spine | 1 | 2021 | 173 | 0.150 |
Why?
| | Drug Prescriptions | 1 | 2021 | 244 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 16 | 0.150 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.150 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 91 | 0.150 |
Why?
| | Anesthesia | 1 | 2022 | 189 | 0.150 |
Why?
| | Medically Underserved Area | 1 | 2019 | 85 | 0.150 |
Why?
| | Cardiotocography | 1 | 2018 | 3 | 0.150 |
Why?
| | Stillbirth | 1 | 2019 | 72 | 0.150 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 251 | 0.150 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 10 | 0.150 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 105 | 0.150 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 71 | 0.150 |
Why?
| | Baths | 1 | 2018 | 14 | 0.150 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.150 |
Why?
| | Outpatients | 1 | 2022 | 393 | 0.150 |
Why?
| | Perioperative Care | 1 | 2020 | 178 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 389 | 0.150 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 16 | 0.150 |
Why?
| | Genotype | 1 | 2023 | 1914 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2022 | 362 | 0.150 |
Why?
| | Nutritional Status | 1 | 2021 | 344 | 0.150 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.150 |
Why?
| | Africa, Western | 1 | 2018 | 17 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4281 | 0.140 |
Why?
| | Adaptive Clinical Trials as Topic | 1 | 2018 | 22 | 0.140 |
Why?
| | Gastroenterology | 1 | 2020 | 181 | 0.140 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 530 | 0.140 |
Why?
| | Cannabinoids | 1 | 2020 | 161 | 0.140 |
Why?
| | Glaucoma | 1 | 2021 | 234 | 0.140 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1796 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5419 | 0.140 |
Why?
| | Phenotype | 2 | 2023 | 3189 | 0.140 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 36 | 0.140 |
Why?
| | Barrett Esophagus | 1 | 2020 | 149 | 0.140 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 43 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 284 | 0.140 |
Why?
| | Hypoxia | 2 | 2025 | 1112 | 0.140 |
Why?
| | Body Mass Index | 4 | 2023 | 2373 | 0.140 |
Why?
| | Penicillin Resistance | 1 | 2017 | 8 | 0.140 |
Why?
| | Dyslipidemias | 1 | 2019 | 176 | 0.140 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 130 | 0.140 |
Why?
| | Serogroup | 1 | 2017 | 44 | 0.130 |
Why?
| | Disinfection | 1 | 2018 | 123 | 0.130 |
Why?
| | Time Factors | 6 | 2025 | 6808 | 0.130 |
Why?
| | Child Behavior | 1 | 2019 | 246 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 163 | 0.130 |
Why?
| | Phentermine | 1 | 2016 | 12 | 0.130 |
Why?
| | Child, Preschool | 8 | 2025 | 10997 | 0.130 |
Why?
| | Swine | 3 | 2024 | 773 | 0.130 |
Why?
| | Respiration, Artificial | 1 | 2021 | 642 | 0.130 |
Why?
| | Parkinson Disease | 1 | 2022 | 490 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 642 | 0.130 |
Why?
| | Biomarkers, Tumor | 1 | 2023 | 1272 | 0.130 |
Why?
| | Cigarette Smoking | 1 | 2018 | 101 | 0.130 |
Why?
| | Burns | 1 | 2021 | 325 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 562 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 229 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2022 | 738 | 0.130 |
Why?
| | Fructose | 1 | 2016 | 112 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 407 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 152 | 0.120 |
Why?
| | Gestational Age | 4 | 2019 | 902 | 0.120 |
Why?
| | Spinal Cord | 3 | 2024 | 370 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 552 | 0.120 |
Why?
| | Internal Medicine | 1 | 2018 | 253 | 0.120 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 115 | 0.120 |
Why?
| | Body Composition | 1 | 2019 | 678 | 0.120 |
Why?
| | United States | 9 | 2024 | 14682 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2022 | 747 | 0.120 |
Why?
| | Mentoring | 1 | 2018 | 144 | 0.120 |
Why?
| | Pain Measurement | 3 | 2025 | 521 | 0.120 |
Why?
| | Missouri | 1 | 2015 | 61 | 0.120 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3264 | 0.120 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 234 | 0.120 |
Why?
| | Adiposity | 2 | 2019 | 518 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2018 | 282 | 0.120 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 169 | 0.120 |
Why?
| | Lung Diseases | 1 | 2022 | 768 | 0.120 |
Why?
| | Meals | 1 | 2016 | 125 | 0.120 |
Why?
| | Suicide | 1 | 2022 | 645 | 0.120 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 305 | 0.120 |
Why?
| | Forests | 1 | 2015 | 62 | 0.110 |
Why?
| | Critical Illness | 1 | 2021 | 804 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 614 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 426 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2022 | 755 | 0.110 |
Why?
| | Length of Stay | 4 | 2021 | 1204 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2018 | 383 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 381 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5739 | 0.110 |
Why?
| | Pilot Projects | 4 | 2021 | 1693 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 842 | 0.110 |
Why?
| | Veterans | 2 | 2022 | 1466 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2019 | 648 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2018 | 525 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 752 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 507 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 926 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 487 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1285 | 0.100 |
Why?
| | Quality of Life | 1 | 2025 | 2876 | 0.100 |
Why?
| | Medicare | 3 | 2024 | 756 | 0.100 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 51 | 0.100 |
Why?
| | Muscle Spasticity | 2 | 2023 | 58 | 0.100 |
Why?
| | Clinical Competence | 1 | 2020 | 1090 | 0.100 |
Why?
| | Minnesota | 3 | 2018 | 162 | 0.100 |
Why?
| | Animals | 5 | 2024 | 36836 | 0.100 |
Why?
| | Seasons | 1 | 2015 | 544 | 0.100 |
Why?
| | Physicians | 1 | 2021 | 905 | 0.100 |
Why?
| | Hospitalization | 1 | 2022 | 2181 | 0.090 |
Why?
| | Electric Impedance | 2 | 2023 | 107 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 833 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 716 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1203 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1127 | 0.090 |
Why?
| | Intensive Care Units | 3 | 2021 | 798 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 87 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1146 | 0.090 |
Why?
| | ROC Curve | 2 | 2024 | 544 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 560 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2123 | 0.090 |
Why?
| | Anxiety | 1 | 2018 | 1031 | 0.090 |
Why?
| | Cohort Studies | 4 | 2021 | 5703 | 0.080 |
Why?
| | Saliva | 2 | 2023 | 242 | 0.080 |
Why?
| | Operating Rooms | 2 | 2022 | 123 | 0.080 |
Why?
| | Cesarean Section | 2 | 2023 | 183 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 594 | 0.080 |
Why?
| | Medical Oncology | 2 | 2022 | 288 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 143 | 0.080 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 159 | 0.080 |
Why?
| | Hemodynamics | 2 | 2024 | 1109 | 0.080 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 141 | 0.080 |
Why?
| | Depression | 1 | 2018 | 1397 | 0.080 |
Why?
| | Prognosis | 3 | 2023 | 4012 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 1936 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5105 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 949 | 0.060 |
Why?
| | Registries | 2 | 2025 | 2014 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1688 | 0.060 |
Why?
| | Mice | 1 | 2022 | 17758 | 0.060 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.060 |
Why?
| | Caregivers | 2 | 2023 | 870 | 0.060 |
Why?
| | False Negative Reactions | 1 | 2024 | 53 | 0.060 |
Why?
| | Uncertainty | 1 | 2025 | 128 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 107 | 0.060 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 56 | 0.060 |
Why?
| | Disease Progression | 2 | 2024 | 2751 | 0.050 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 60 | 0.050 |
Why?
| | Quality Control | 1 | 2024 | 171 | 0.050 |
Why?
| | Neck | 1 | 2024 | 101 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 31 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Patient Positioning | 1 | 2024 | 67 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 30 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 60 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2024 | 71 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 57 | 0.050 |
Why?
| | Epinephrine | 1 | 2023 | 139 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 114 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1615 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3540 | 0.050 |
Why?
| | Edema | 1 | 2023 | 129 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2829 | 0.050 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 233 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 88 | 0.050 |
Why?
| | Rotator Cuff | 1 | 2022 | 47 | 0.050 |
Why?
| | Esophageal Sphincter, Upper | 1 | 2021 | 7 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 115 | 0.050 |
Why?
| | Goals | 1 | 2023 | 169 | 0.050 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.050 |
Why?
| | Patients | 1 | 2023 | 174 | 0.050 |
Why?
| | Motor Skills | 1 | 2022 | 97 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 186 | 0.050 |
Why?
| | Malawi | 1 | 2021 | 53 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 206 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2022 | 143 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 497 | 0.040 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 95 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 22 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 750 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 193 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 65 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 183 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 12 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 262 | 0.040 |
Why?
| | Noise | 1 | 2021 | 67 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 7 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3432 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 2 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 73 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 143 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 8 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 53 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 573 | 0.040 |
Why?
| | Iron | 1 | 2022 | 312 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 20 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 446 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 206 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 28 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 50 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 528 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 4145 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4512 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 417 | 0.040 |
Why?
| | Hemorrhage | 1 | 2024 | 720 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 593 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 417 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 305 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 83 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 13 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 292 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 136 | 0.040 |
Why?
| | Chlorhexidine | 1 | 2018 | 23 | 0.040 |
Why?
| | Patient Care Bundles | 1 | 2018 | 23 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 785 | 0.040 |
Why?
| | Analgesics | 1 | 2020 | 206 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2018 | 89 | 0.040 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 14 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2020 | 169 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2020 | 276 | 0.040 |
Why?
| | Nasal Cavity | 1 | 2018 | 52 | 0.040 |
Why?
| | Staff Development | 1 | 2018 | 56 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 123 | 0.040 |
Why?
| | Catheters | 1 | 2018 | 72 | 0.040 |
Why?
| | Carrier State | 1 | 2018 | 67 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 361 | 0.040 |
Why?
| | Chronic Disease | 1 | 2024 | 1786 | 0.030 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 228 | 0.030 |
Why?
| | Comorbidity | 1 | 2022 | 1614 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 656 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 318 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 13126 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 343 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 18 | 0.030 |
Why?
| | Africa | 1 | 2017 | 108 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 303 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 333 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 55 | 0.030 |
Why?
| | Risk | 1 | 2019 | 908 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 204 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 587 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 901 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1350 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 89 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 514 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1282 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 351 | 0.030 |
Why?
| | Preoperative Care | 1 | 2018 | 356 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 935 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 331 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 544 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 254 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 108 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 259 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 218 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1351 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1962 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1940 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2016 | 258 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 564 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 399 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2047 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2067 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1162 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1707 | 0.020 |
Why?
| | Primary Health Care | 1 | 2023 | 1722 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 978 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2016 | 1982 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1340 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1274 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2406 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|